Musculoskeletal implants specialist restor3d successfully commercialized femoral implants produced via a previously cleared additive manufacturing method, outperforming the mechanical properties of cast implants. The initiative comes upon the finalization of the acquisition of Conformis, Inc by restor3d. With this merger complete, the company sees a tremendous opportunity to deliver clinically differentiated and cost-effective solutions across the orthopedic landscape.
“We are thrilled to announce the successful achievement of one of our key initiatives post-acquisition,” stated Kurt Jacobus, Chief Executive Officer of restor3d. “Patient-specific femoral implants, which have traditionally been cast at low margin, are now 3D printed at a fraction of the cost at our facility in Durham, NC.”
restor3d is a world leader in patient-specific musculoskeletal implants. The company holds proprietary expertise in 3D printing of osseointegrative materials, AI-based planning and design automation tools, and digital health solutions to provide seamless data-backed care to optimize individual patient outcomes.
Among other things, restor3d developed TIDAL Technology, an optimized porous architecture designed for osseointegration where implants are additively manufactured via laser powder bed fusion of titanium or cobalt chrome alloys. restor3d produces all implants using in-house 3D printing capabilities and proprietary manufacturing processes. Alongside its customers, restor3d is reimagining the musculoskeletal reconstruction landscape.
“Total knee replacement is entering an era of personalization,” said Dr. Moby Parsons, MD, a Board-Certified orthopedic surgeon at Portsmouth Regional Hospital. “Nowhere is this more important than implant design and I believe this is a critical element of achieving the better outcomes that today’s patients expect. restor3d’s printed patient-specific femurs take personalization to the next level of innovation in knee replacement using form and fit to help achieve a more normal feeling. I owe it to my patients to provide the best outcome possible in every case, and this technology is a key solution to that goal.
